Clinical Trial Update: Study of WST11 in Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating WST11 in men with localized prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• WST11 (WST11)

Snippet

Sponsor: Steba Biotech S.A. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED